Understanding how factors such as excipient choice affect nitrosamine formation is essential to developing safer, lower-risk pharmaceutical formulations.
Joseph Zeleznik
Advertisement
Joseph Zeleznik is technical product director, IMCD US
Articles by Joseph Zeleznik
Key information is needed for excipients and their potential impact on continuous manufacturing processes.
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Advertisement
Latest Updated Articles
Understanding Concomitant Components in Pharmaceutical ExcipientsFebruary 2nd 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5